AU2003264861A1 - Novel crystalline forms of celecoxib - Google Patents
Novel crystalline forms of celecoxibInfo
- Publication number
- AU2003264861A1 AU2003264861A1 AU2003264861A AU2003264861A AU2003264861A1 AU 2003264861 A1 AU2003264861 A1 AU 2003264861A1 AU 2003264861 A AU2003264861 A AU 2003264861A AU 2003264861 A AU2003264861 A AU 2003264861A AU 2003264861 A1 AU2003264861 A1 AU 2003264861A1
- Authority
- AU
- Australia
- Prior art keywords
- celecoxib
- crystalline forms
- novel crystalline
- novel
- forms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- RZEKVGVHFLEQIL-UHFFFAOYSA-N celecoxib Chemical compound C1=CC(C)=CC=C1C1=CC(C(F)(F)F)=NN1C1=CC=C(S(N)(=O)=O)C=C1 RZEKVGVHFLEQIL-UHFFFAOYSA-N 0.000 title 1
- 229960000590 celecoxib Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IN2003/000267 WO2005014546A1 (en) | 2003-08-08 | 2003-08-08 | Novel crystalline forms of celecoxib |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2003264861A1 true AU2003264861A1 (en) | 2005-02-25 |
Family
ID=34131130
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003264861A Abandoned AU2003264861A1 (en) | 2003-08-08 | 2003-08-08 | Novel crystalline forms of celecoxib |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2003264861A1 (en) |
| WO (1) | WO2005014546A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1846377A2 (en) * | 2005-01-31 | 2007-10-24 | Pharmacia & Upjohn Company LLC | Form iv crystalline celecoxib |
| WO2011055233A2 (en) | 2009-11-03 | 2011-05-12 | Actavis Group Ptc Ehf | Improved process for preparing celecoxib polymorph |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1144383A1 (en) * | 1999-01-14 | 2001-10-17 | Merck Frosst Canada & Co. | Synthesis of 4-[(5-substituted or unsubstituted phenyl)-3-substituted-1h-pyrazol-1-yl]benzenesulfonamides |
| UA74539C2 (en) * | 1999-12-08 | 2006-01-16 | Pharmacia Corp | Crystalline polymorphous forms of celecoxib (variants), a method for the preparation thereof (variants), a pharmaceutical composition (variants) |
-
2003
- 2003-08-08 AU AU2003264861A patent/AU2003264861A1/en not_active Abandoned
- 2003-08-08 WO PCT/IN2003/000267 patent/WO2005014546A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005014546A1 (en) | 2005-02-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003230192A1 (en) | Novel crystalline forms of aripiprazole | |
| AU2003291579A1 (en) | Yield improvement | |
| AU2003239644A1 (en) | Crystallization of sugars | |
| AU2003273083A1 (en) | Compositions for the improvement of obesity | |
| AU2003238671A1 (en) | Novel crystalline forms of s-omeprazole magnesium | |
| AU2003245029A1 (en) | Novel crystalline forms of donepezil hydrochloride | |
| AU2003245027A1 (en) | Novel crystalline forms of ziprasidone hydrochloride | |
| AU2003232719A1 (en) | Novel crystalline forms of valacyclovir hydrochloride | |
| AU2003222439A1 (en) | Novel crystalline forms of tegaserod maleate | |
| AU2003230193A1 (en) | Novel crystalline forms of candesartan cilexetil | |
| AU2003217438A1 (en) | Novel crystalline forms of levetiracetam | |
| AU2003264861A1 (en) | Novel crystalline forms of celecoxib | |
| AU2003217437A1 (en) | Novel crystalline forms of lamotrigine | |
| AU2003257541A1 (en) | Novel crystals | |
| AU2003238668A1 (en) | Novel crystalline forms of valdecoxib | |
| AU2003238669A1 (en) | Novel crystalline forms of parecoxib sodium | |
| AU2002251329A1 (en) | Novel crystalline forms of celecoxib and other compounds | |
| AU2003238678A1 (en) | Novel crystalline forms of sumatriptan succinate | |
| AU2003230194A1 (en) | Novel crystalline forms of gatifloxacin | |
| AU2003242983A1 (en) | Novel crystalline forms of abacavir sulfate | |
| AU2002219436A1 (en) | An improved synthesis of ceftiofur intermediate | |
| AU2003209670A1 (en) | Novel crystalline forms of trandolapril | |
| AU2003242984A1 (en) | A novel crystalline form of irbesartan | |
| AU2003217354A1 (en) | Synthesis of sulfamidates | |
| AU2003217439A1 (en) | Novel crystalline forms of finasteride |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |